PDK1 and prostate cancer: This presents a potential mechanism for the physiological regulation of PDK1 turnover by E3 ligase SPOP, and further dictate the pathological conditions of prostate cancer, where patients conceived SPOP mutations, or PDK1 degron-associated mutations facilitate tumorigenesis by activating AKT kinase.